Pulmonary Health in Children With Down Syndrome

Sponsor
University of Colorado, Denver (Other)
Overall Status
Recruiting
CT.gov ID
NCT04398862
Collaborator
National Heart, Lung, and Blood Institute (NHLBI) (NIH)
75
1
36.3
2.1

Study Details

Study Description

Brief Summary

The goal of the study is to learn more about tests that can assess lung health in children with Down syndrome.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    75 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Prospective
    Official Title:
    Measures of Pulmonary Health in Children With Down Syndrome
    Actual Study Start Date :
    Aug 21, 2020
    Anticipated Primary Completion Date :
    Aug 30, 2023
    Anticipated Study Completion Date :
    Aug 30, 2023

    Arms and Interventions

    Arm Intervention/Treatment
    Children with Down syndrome and aspiration

    Outcomes will be compared between two groups although no intervention is submitted, this is an observational study.

    Children with Down syndrome without aspiration

    Outcomes will be compared between two groups although no intervention is submitted, this is an observational study.

    Outcome Measures

    Primary Outcome Measures

    1. Total airway resistance [Baseline]

      Airway resistance (R5) measured using forced oscillation technique at 5 Hertz

    2. Airway reactance [Baseline]

      Airway reactance (X5) measured using forced oscillation technique at 5 Hertz

    Secondary Outcome Measures

    1. Change in total airway resistance after albuterol [Baseline]

      Airway resistance (R5) measured using forced oscillation technique at 5 Hertz before and after administration of albuterol

    2. Change in airway reactance after albuterol [Baseline]

      Airway reactance (X5) measured using forced oscillation technique at 5 Hertz before and after administration of albuterol

    3. Health-related quality of life, as measured by the Pediatric Quality of Life Inventory [Baseline]

      The Pediatric Quality of Life Inventory (PedsQL) assesses four domains of quality of life. Results are converted to a score from 0-100, where low numbers are low quality of life and higher numbers is better quality of life.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    3 Years to 18 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Children aged 3 to 18 years, inclusive, at time of consent

    • Diagnosis of Down syndrome/trisomy 21 or mosaicism

    • Able to walk

    • Had a swallow study (video fluoroscopic swallow study or fiberoptic endoscopic evaluation of swallowing) performed within 5 years of consent date

    Exclusion Criteria:
    • Pregnant or lactating

    • Nonambulatory

    • Have a tracheostomy or other known severe glottic or subglottic obstruction that would significantly affect the results of testing

    • Have a significant acute respiratory illness, defined as treatment with steroids, antibiotics, or an increase in supplemental oxygen

    • have a medical illness that would a)increase the risk the participate would incur by participating in the study, b) interfere with the outcomes of the study, or c) interfere with the performance of study participants

    • Have a severe behavioral problem that would interfere with the performance of study procedures

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Children's Hospital Colorado Aurora Colorado United States 80045

    Sponsors and Collaborators

    • University of Colorado, Denver
    • National Heart, Lung, and Blood Institute (NHLBI)

    Investigators

    • Principal Investigator: Emily DeBoer, MD, MSCS, University of Colorado, Denver

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University of Colorado, Denver
    ClinicalTrials.gov Identifier:
    NCT04398862
    Other Study ID Numbers:
    • 19-2092
    • R21HL151261-01
    First Posted:
    May 21, 2020
    Last Update Posted:
    Jan 27, 2022
    Last Verified:
    Jan 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by University of Colorado, Denver
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jan 27, 2022